Vaccination against Eimeria tenella infection using a fraction of E. tenella sporozoites selected by the capacity to activate T cells.
At 8 days after a primary Eimeria tenella infection, a subset of T cells, of which the protective role is as yet unclear, circulates in the peripheral blood. In order to investigate this, the in vitro cellular responsiveness of these peripheral blood lymphocytes has been used as selection criterion to identify potentially protective E. tenella sporozoite antigens. The hydrophilic protein phase of purified E. tenella sporozoite homogenates obtained by Triton X-114 extraction was fractionated using preparative gel electrophoresis. Nine fractions, separated according to different molecular weight, were tested for their ability to stimulate T-cell responses. Both the proliferation of peripheral blood lymphocytes and the macrophage activating activity released in the culture supernatants were measured. On the basis of this responsiveness, four fractions were selected and used to vaccinate chickens. All vaccine preparations induced strong T-cell responses. One fraction immunised chickens against subsequent challenge infection, in that the caecal lesion scores were significantly lower as compared with that of the unvaccinated controls. This fraction contained hydrophilic polypeptides with a molecular mass that ranged from 26 to 30 kDa.
Breed
D G
DG
Department of Parasitology, Intervet International BV, Boxmeer, The Netherlands.
Schetters
T P
TP
Verhoeven
N A
NA
Boot-Groenink
A
A
Dorrestein
J
J
Vermeulen
A N
AN
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology / Q000302:isolation & purification; D002645:Chickens / Q000276:immunology*; D003048:Coccidiosis / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D004306:Dose-Response Relationship, Immunologic; D016786:Eimeria tenella / Q000254:growth & development / Q000276:immunology*; D004587:Electrophoresis, Agar Gel; D008213:Lymphocyte Activation; D008262:Macrophage Activation; D017830:Octoxynol; D011092:Polyethylene Glycols; D011201:Poultry Diseases / Q000276:immunology / Q000517:prevention & control*; D015800:Protozoan Proteins / Q000276:immunology / Q000302:isolation & purification; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014611:Vaccination / Q000662:veterinary
D000953:Antigens, Protozoan; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; D011092:Polyethylene Glycols; D017830:Octoxynol; C010615:Nonidet P-40